Pain
Conference Coverage
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors
ATLANTA – “For any individual patient, a single option may be chosen at a particular time point, perhaps with or without other options, and may be...
News from the FDA/CDC
FDA announces approval of fifth adalimumab biosimilar, Abrilada
Pfizer said that current plans are to launch the drug in the United States in 2023.
Perspectives
CBD: What physicians need to know about it
An internist describes the benefits and risks of using cannabidiol to treat various conditions.
Feature
Drug crisis continues to evolve beyond opioids
Primary care physicians “are well intentioned but underprepared and may miss some of the drug misuse risks affecting their patients,” says the...
From the Journals
Preop IV dexamethasone conveys relief after total knee surgery
Injection of intravenous dexamethasone reduced pain from 12 to 21 hours after knee arthroplasty compared with placebo.
Conference Coverage
Consider centralized pain in patients with rheumatic disease
LAS VEGAS – Every patient with chronic pain should complete a fibromyalgia survey, Dr. Daniel J. Clauw says.
Latest News
CDC, SAMHSA commit $1.8 billion to combat opioid crisis
Some of the funds will be used to help improve overdose monitoring.
From the Journals
Cannabidiol may interact with rheumatologic drugs
CBD is known to inhibit the cytochrome P450 enzymes that metabolize corticosteroids and other medications.
From the Journals
Peripheral nervous system events have lasting impact on SLE patients
Findings from one of the largest-ever cohort studies on PNS manifestations in SLE patients may “provide a benchmark for the assessment of future...
From the Journals
Preoperative tramadol fails to improve function after knee surgery
Patients given preoperative tramadol showed less improvement at 3 months than those given narcotics or no opiates.
News
FDA approves first generics of pregabalin
The first generic approvals of the drug were granted to nine companies.